Clough Capital Partners’s Prothena Corp PRTA Stock Holding History

Clough Capital Partners’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-38,400	Closed	-$2.62M	–	236
2015 Q4	$2.62M	Sell	38,400 -27,000	-41%	-$1.63M	0.12%	119
2015 Q3	$2.96M	Sell	65,400 -4,000	-6%	-$233K	0.13%	118
2015 Q2	$3.65M	Sell	69,400 -75,800	-52%	-$2.99M	0.14%	121
2015 Q1	$5.54M	Buy	145,200 +12,200	+9%	+$313K	0.18%	127
2014 Q4	$2.76M	Buy	133,000 +31,500	+31%	+$657K	0.1%	136
2014 Q3	$2.25M	Sell	101,500 -4,300	-4%	-$91.2K	0.08%	141
2014 Q2	$2.39M	Buy	+105,800	New	+$2.65M	0.08%	154

Other funds holding PRTA

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Clough Capital Partners's PRTA Position: Q1 2016 in Review

Clough Capital Partners sold out of Prothena Corp (PRTA) in Q1 2016, closing a stake of 38,400 shares — an estimated $2.62M sold.

Clough Capital Partners first reported a position in PRTA in Q2 2014 and held it in 7 quarters. The position peaked at $5.54M in Q1 2015. 144 funds tracked by Wall St. Rank hold PRTA as of Q1 2016.

Clough Capital Partners reported no remaining Prothena Corp position as of Q1 2016 after selling out during the quarter.
Clough Capital Partners sold 38,400 Prothena Corp shares in Q1 2016, an estimated $2.62M.
Clough Capital Partners first reported a position in Prothena Corp in Q2 2014 and held it in 7 quarters.
Clough Capital Partners's Prothena Corp position peaked at $5.54M in Q1 2015.
144 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2016.

Based on Clough Capital Partners's 13F filing for Q1 2016, filed 16 May 2016.